A large percentage of human type 1 diabetes is known to be associated with altered forms of the major histocompatibilty complex (MHC), a group of proteins made by immune cells that regulate many of the functions of the immune system. Evan David Rosen, M.D brings us up to date on …
Read More »Axokine Promotes Weight Loss For Patients with Type 2 Diabetes
Axokine, a modified ciliary neurotrophic factor, appears to promote weight loss in overweight and obese patients with type 2 diabetes, according to the findings of a 12-week randomized trial.
Read More »Diabetes 101
Learning objectives Upon completion of this chapter, the technician should be able to do the following: 1. Differentiate between Type 1 and Type 2 Diabetes. 2. Explain the Criteria for the diagnosis of Diabetes. 3. Explain Insulin Resistance. 4. Discuss the importance of monitoring blood sugars. 5. Explain the purpose …
Read More »Prandin (Repaglinide) Approved for Combination Therapy With Ins
Studies Show Greater Glycemic Improvements With Prandin and Sensitizers Compared to Monotherapy in Treating Type 2 Diabetes
Read More »Adding Insulin “Before” Sulfonylurea Inadequacy
Within 6 years patients with Type 2 diabetes will require another medication after starting on sulfonylurea. Then why don’t we add small doses of insulin prior to need? Should we be chasing elevated blood sugars or should be treating to prevent them?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.